{
    "laboratory_examinations": [
        {
            "procedure_name": "Ficolin-3 Serum Level Measurement",
            "date": "Not specified",
            "findings": "0 μg per milliliter (homozygous patient); 14.1 μg per milliliter (heterozygous patients); 27.5 μg per milliliter (normal genotype patients).",
            "changes_over_time": "Heterozygous patients exhibited approximately 50% of ficolin-3 serum levels compared to wild-type FCN3 patients."
        },
        {
            "procedure_name": "Immunoglobulin Levels Measurement",
            "date": "Not specified",
            "findings": "IgM level was 0.24 g per liter (reference range: 0.29 to 2.0), normal levels for IgG, IgG subclasses, and IgA.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Complement Pathway Activity Measurement",
            "date": "Not specified",
            "findings": "Normal activity of classical, MBL, and alternative complement pathways.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Leukocyte Count",
            "date": "Not specified",
            "findings": "Leukocytes: 4.8 x 10^6/ml; Neutrophils: 4.8 x 10^6/ml; Lymphocytes: 3.9 x 10^6/ml.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Pulmonary Function Tests",
            "date": "Over a period of 6 years",
            "findings": "Progressively decreased lung capacity and obstructive lung disease.",
            "changes_over_time": "Decreased lung capacity observed over time despite treatment."
        }
    ]
}